Catalyst Wire Dossier Catalyst Wire Dossier

Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride

Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride · H2-Pharma, LLC
Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride, covering 2006-09-28 to 2025-11-21. Get the full timeline:

Most recent: FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)

See pricing